Clinical features, risk factors and outcomes of bacteremia due to enterococci with high-level gentamicin resistance: Comparison with bacteremia due to enterococci without high-level gentamicin resistance

Journal of Korean Medical Science

Volumn 25, Issue 1, 2010, Pages 3-8

  Jang, Hee Chang ^a   Lee, Shinwon ^a   Song, Kyoung Ho ^a   Jeon, Jae Hyun ^a   Park, Wan Beom ^a   Park, Sang Won ^a   Kim, Hong Bin ^a   Kim, Nam Joong ^a   Kim, Eui Chong ^a   Oh, Myoung don ^a   Choe, Kang Won ^a  

^a Seoul National University College of Medicine   (South Korea)

Author keywords

Bacteremia; Combination; Drug therapy; Enterococcus; Gentamicins; HLGR; Mortality

Indexed keywords

ANTIINFECTIVE AGENT; CEPHALOSPORIN DERIVATIVE; GENTAMICIN;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; BACTEREMIA; COMPARATIVE STUDY; CROSS INFECTION; DRUG EFFECT; ENTEROCOCCUS; FEMALE; GRAM POSITIVE INFECTION; HOSPITALIZATION; HUMAN; ISOLATION AND PURIFICATION; MALE; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; NEUTROPENIA; RISK; RISK FACTOR; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; ANTI-BACTERIAL AGENTS; BACTEREMIA; CEPHALOSPORINS; CROSS INFECTION; DRUG RESISTANCE, BACTERIAL; ENTEROCOCCUS; FEMALE; GENTAMICINS; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEUTROPENIA; ODDS RATIO; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 77949318753     PISSN: 10118934     EISSN: 15986357     Source Type: Journal    
DOI: 10.3346/jkms.2010.25.1.3     Document Type: Article

References (25)

1. Wisplinghoff H, Bischoff T, Tallent SM, Seifert H, Wenzel RP, Edmond MB. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis 2004; 39: 309-17.
2. Lee K, Jang SJ, Lee HJ, Ryoo N, Kim M, Hong SG, Chong Y. Increasing prevalence of vancomycin-resistant enterococcus faecium, expanded-spectrum cephalosporin-resistant klebsiella pneumoniae, and imipenem-resistant pseudomonas aeruginosa in Korea: KONSAR study in 2001. J Korean Med Sci 2004; 19: 8-14.
3. Lee K, Lee HS, Jang SJ, Park AJ, Lee MH, Song WK, Chong Y; Members of Korean Nationwide Surveillance of Antimicrobial Resistance Group. Antimicrobial resistance surveillance of bacteria in 1999 in Korea with a special reference to resistance of enterococci to vancomycin and gram-negative bacilli to third generation cephalosporin, imipenem, and fluoroquinolone. J Korean Med Sci 2001; 16: 262-70.
4. Murray BE. The life and times of the enterococcus. Clin Microbiol Rev 1990; 3: 46-65.
5. Wessels MR. Streptococcal and enterococcal infections. In: Fauci AS, Braunwald E, Kasper DL, Hauser SL, Longo DL, Jameson JL, Loscalzo J, eds. Harrison's principles of internal medicine, 17th ed. New York: McGraw-Hill 2008; 881-90.
6. Moellering RC Jr. Enterococcus species, Streptococcus bovis, and Leuconostoc species. In: Mandell GL, Bennet JE, Dolin R, eds. Mandell, Douglas, and Bennett's Principles and practice of infectious diseases, 6th ed. Philadelphia: Churchill Livingstone 2005; 2411-21.
7. Noskin GA, Till M, Patterson BK, Clarke JT, Warren JR. High-level gentamicin resistance in Enterococcus faecalis bacteremia. J Infect Dis 1991; 164: 1212-5.
8. Huycke MM, Spiegel CA, Gilmore MS. Bacteremia caused by hemolytic, high-level gentamicin-resistant Enterococcus faecalis. Antimicrob Agents Chemother 1991; 35: 1626-34.
9. Wells VD, Wong ES, Murray BE, Coudron PE, Williams DS, Markowitz SM. Infections due to beta-lactamase-producing, high-level gentamicin-resistant Enterococcus faecalis. Ann Intern Med 1992; 116: 285-92.
10. Watanakunakorn C, Patel R. Comparison of patients with enterococcal bacteremia due to strains with and without high-level resistance to gentamicin. Clin Infect Dis 1993; 17: 74-8.
11. Caballero-Granado FJ, Cisneros JM, Luque R, Torres-Tortosa M, Gamboa F, Diez F, Villanueva JL, Perez-Cano R, Pasquau J, Merino D, Menchero A, Mora D, Lopez-Ruz MA, Vergara A. Comparative study of bacteremias caused by Enterococcus spp. with and without high-level resistance to gentamicin. The Grupo Andaluz para el estudio de las Enfermedades Infecciosas. J Clin Microbiol 1998; 36: 520-5.
12. Shaked H, Carmeli Y, Schwartz D, Siegman-Igra Y. Enterococcal bacteraemia: epidemiological, microbiological, clinical and prognostic characteristics, and the impact of high level gentamicin resistance. Scand J Infect Dis 2006; 38: 995-1000.
13. Vergis EN, Hayden MK, Chow JW, Snydman DR, Zervos MJ, Linden PK, Wagener MM, Schmitt B, Muder RR. Determinants of vancomycin resistance and mortality rates in enterococcal bacteremia. a prospective multicenter study. Ann Intern Med 2001; 135: 484-92.
14. Facklam RR, Collins MD. Identification of Enterococcus species isolated from human infections by a conventional test scheme. J Clin Microbiol 1989; 27: 731-4.
15. Devriese LA, Pot B, Kersters K, Lauwers S, Haesebrouck F. Acidification of methyl-alpha-D-glucopyranoside: a useful test to differentiate Enterococcus casseliflavus and Enterococcus gallinarum from Enterococcus faecium species group and from Enterococcus faecalis. J Clin Microbiol 1996; 34: 2607-8.
16. Clinical and Laboratory Standards Institute (CLSI). Performance standards for antimicrobial susceptibility testing; eighteenth informational supplement. Wayne, PA: Clinical and Laboratory Standards Institute (CLSI), 2008; M100-S18.
17. Chow JW, Fine MJ, Shlaes DM, Quinn JP, Hooper DC, Johnson MP, Ramphal R, Wagener MM, Miyashiro DK, Yu VL. Enterobacter bacteremia: clinical features and emergence of antibiotic resistance during therapy. Ann Intern Med 1991; 115: 585-90.
18. Handwerger S, Raucher B, Altarac D, Monka J, Marchione S, Singh KV, Murray BE, Wolff J, Walters B. Nosocomial outbreak due to Enterococcus faecium highly resistant to vancomycin, penicillin, and gentamicin. Clin Infect Dis 1993; 16: 750-5.
19. Boyle JF, Soumakis SA, Rendo A, Herrington JA, Gianarkis DG, Thurberg BE, Painter BG. Epidemiologic analysis and genotypic characterization of a nosocomial outbreak of vancomycin-resistant enterococci. J Clin Microbiol 1993; 31: 1280-5.
20. Boyce JM, Opal SM, Chow JW, Zervos MJ, Potter-Bynoe G, Sherman CB, Romulo RL, Fortna S, Medeiros AA. Outbreak of multidrugresistant Enterococcus faecium with transferable vanB class vancomycin resistance. J Clin Microbiol 1994; 32: 1148-53.
21. Elliott TS, Foweraker J, Gould FK, Perry JD, Sandoe JA. Guidelines for the antibiotic treatment of endocarditis in adults: report of the Working Party of the British Society for Antimicrobial Chemotherapy. J Antimicrob Chemother 2004; 54: 971-81.
22. Hoge CW, Adams J, Buchanan B, Sears SD. Enterococcal bacteremia: to treat or not to treat, a reappraisal. Rev Infect Dis 1991; 13: 600-5.
23. Graninger W, Ragette R. Nosocomial bacteremia due to Enterococcus faecalis without endocarditis. Clin Infect Dis 1992; 15: 49-57.
24. Gullberg RM, Homann SR, Phair JP. Enterococcal bacteremia: analysis of 75 episodes. Rev Infect Dis 1989; 11: 74-85.
25. Maki DG, Agger WA. Enterococcal bacteremia: clinical features, the risk of endocarditis, and management. Medicine (Baltimore) 1988; 67: 248-69.